Clinical significance and future of the prognostic factors uPA and PAI-1 for nodal-negative invasive breast cancer

被引：0
|
作者：
Streckert, I [1 ]
Bonatz, G. [2 ]
Kucharski, K. [3 ]
Marek, W.
Streckert, H. J.
Phillipou, S.
机构：
[1] Augusta Krankenanstalten, Inst Pathol & Zytol, Inst Pathol, Bochum, Germany
[2] Augusta Krankenanstalten, Bochum, Germany
[3] Malteser Krankenhaus St Anna, Brustzentrum Duisburg, Duisburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2008年 / 68卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：304 / 304
页数：1
相关论文
共 50 条
  • [41] uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies
    Duffy, Michael J.
    McGowan, Patricia M.
    Harbeck, Nadia
    Thomssen, Christoph
    Schmitt, Manfred
    BREAST CANCER RESEARCH, 2014, 16 (04):
  • [42] PAI-1 and PAI-2 as predictive factors in breast cancer
    Matos, E.
    Borstnar, S.
    Vrhovec, I.
    Svetic, B.
    Cufer, T.
    EJC SUPPLEMENTS, 2004, 2 (03): : 181 - 182
  • [43] Model for the Quantification of the health-economic Consequences of a Riskgroup-Sample based on the ASCO-recommended Biomarkers uPA and PAI-1 in nodal-negative primary Mammary Carcinoma
    Jacobs, V. R.
    Kates, R.
    Kantelhardt, E. J.
    Vetter, M.
    Schmitt, M.
    Jaenicke, F.
    Untch, M.
    Thomssen, C.
    Harbeck, N.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (04)
  • [44] PAI-1 promoter polymorphism modulates uPA-PAI complex accumulation by breast cancer cells
    Alvarez-Millán, JJ
    Bocos, C
    Ferrín, V
    Lucas, AR
    Ruibal, A
    Schneider, J
    ONCOLOGY, 2002, 62 (03) : 286 - 290
  • [45] Time varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer
    Schmitt, M
    Thomssen, C
    Ulm, K
    Seiderer, A
    Harbeck, N
    Hofler, H
    Janicke, F
    Graeff, H
    BRITISH JOURNAL OF CANCER, 1997, 76 (03) : 306 - 311
  • [46] Tumor-biological factors uPA and PAI-1 as stratification criteria of a multicenter adjuvant chemotherapy trial in node-negative breast cancer
    Prechtl, A
    Harbeck, N
    Thomssen, C
    Meisner, C
    Braun, M
    Untch, M
    Wieland, M
    Lisboa, B
    Cufer, T
    Graeff, H
    Selbmann, K
    Schmitt, M
    Jänicke, F
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (01): : 73 - 78
  • [47] PROGNOSTIC FACTORS UPA AND PAI-1: FEASIBILITY AND VALIDITY OF DETERMINATION IN CLINICAL ROUTINE AND THE NNBC 3-EUROPE TRIAL
    Vetter, M.
    Harbeck, N.
    Dittmer, J.
    Abraha-Spaeth, S. R.
    Bauerfeind, U.
    Lantzsch, T.
    Sweep, F.
    Schmitt, M.
    Minckwitz, G. V.
    Thomssen, C.
    ANNALS OF ONCOLOGY, 2009, 20 : 54 - 55
  • [48] Association of uPA, PAI-1, and uPAR in nipple aspirate fluid (NAF) with breast cancer
    Qin, WY
    Zhu, WZ
    Wagner-Mann, C
    Folk, W
    Sauter, ER
    CANCER JOURNAL, 2003, 9 (04): : 293 - 301
  • [49] Influence of preoperative core biopsies on uPA/PAI-1 expression in breast cancer tissue
    Susanne Haas
    Tjoung-Won Park
    Jens Claus Hahne
    Hans-Peter Fischer
    Virchows Archiv, 2008, 452 : 277 - 283
  • [50] Determination of ASCO recommended prognostic factors uPA and PAI-1 in daily clinical routine and the node-negative NNBC 3-Europe trial
    Thomssen, C.
    Vetter, M.
    Geurts-Moespot, A.
    Kantelhardt, E. J.
    Veyret, C.
    Schmidt, M.
    Meisner, C.
    von Minckwitz, G.
    Hanf, V
    Martin, P.
    Augustin, D.
    Abraha-Spaeth, S. R.
    Schmitt, M.
    Sweep, F.
    Paepke, D.
    Harbeck, N.
    CANCER RESEARCH, 2009, 69 (02) : 133S - 133S
12345